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Introduction
Most large prospective studies of thrombolysis in acute myoardial infarction have shown a significant reduction in infarct size and improvement in survival vs standard treatment' . One reason for this apparent disparity of treatment effects may be slow recovery of post-ischaemic LV dysfunction. In clinical studies, LV function was usually assessed within the first few days after the acute infarct, before hospital discharge; however, experimental studies indicated that depending on the duration of the acute occlusion, full recovery of LV function may take several weeks' 10 " 1 . Since left ventricular ejection fraction (LVEF) remains fairly constant in patients after myocardial infarction without thrombolysis 1121 , the aim of this study was to determine whether there would be an improvement in LVEF after hospital discharge in patients with early reperfusion, compared with those without reperfusion.
Methods
Since this study represents a substudy of the multicentre European Cooperative Study comparing the effects of recombinant tissue-type plasminogen activator (rtPA) vs placebo on LV function, the methods were identical to those reported earlier 161 . In short, patients below 71 years of age with acute chest pain lasting more than 30 min and significant ST-elevation in more than one lead who could be treated within 5 h of pain onset were randomized to 100 mg of rtPA or placebo, each combined with heparin and aspirin. Coronary and LV angiograms were only performed before hospital discharge, i.e. in our hospital on the 10th day after the acute event.
In addition to the general protocol, our patients underwent creatine kinase (CK) determinations every 4 h during the initial 24 h to detect early reperfusion, defined a priori for this study as time to peak CK of < 15 h; in addition radionuclide angiocardiograms were performed at rest 1 day prior to the contrast ventriculogram and 3 months later, after withdrawal of all cardiac medication for at least 24 h. The 317 CK values determined at our hospital as well as in the central laboratory of the European Cooperative Study in Maastricht' 61 showed excellent agreement: y = -7-1 + 2-9x, r = 0-92, /> < 00001. LVEF determinations by our radionuclide technique and by the centrally analysed contrast ventriculograms showed also a significant correlation (y = 29-3+0-5x, r = 0-7, /><00001), despite the fact that they were measured on different days and with different laboratory conditions. We have previously shown that the radionuclide LVEF values are valid and reproducible with a variability of 2 standard deviations (95%) of <5EF%' 1314 '.
PATIENTS
Included in this study were all 33 patients from our hospital, participating in the European Cooperative Study, who survived the acute event and follow-up and who had both early and follow-up radionuclide studies. There were 27 men and six women, with a mean age of 53-9 years (27-70 years). Ten patients had an anterior and 23 an inferior infarct, 18 had received rtPA and 15 '; in this group no significant change was expected with time; 17 patients had an abnormal value of <50% (Table 1 ). There were no significant differences between the two groups, although more patients with a depressed LVEF had received rtPA.
Statistics
All values are given as mean± 1 SEM. Groups were compared by Student's Mest for unpaired samples or the Chi square test, where appropriate, and values within one group were compared by Student's /-test for paired samples. P values <0-05 were considered statistically significant, <010 as ofborderline significance and >0-10as non-significant.
Results
Changes in LV function between early and follow-up studies for patients with initially normal and abnormal LVEF values are shown in Fig. 1 . In patients with an LVEF of ^50%, values remained fairly constant over time, whereas they increased significantly in patients with a depressed value on day 9. This increase was markedly higher than the spontaneous variability of this measurement with time 114 '. In order to define factors responsible for this improvement in LVEF over time, patients with an initial value of < 50% were subdivided by time to peak CK (as a marker of early reperfusion) and drug treatment given (Fig. 2) . There was a significant improvement only in patients with enzymatic signs of early reperfusion. Similarly, only patients who received rtPA showed a signficant late improvement of LVEF (from 37-8 + 3-2 to 46-5 + 4-6%, P < 001; only one patient in each subgroup of Fig. 2 had to be exchanged).
When patients were subdivided by vessel patency according to the 10 day coronary angiogram, improvement of LVEF over time was only of borderline significance for eight patients with an open infarct-related artery (from 38-9 ±4-5 to 441 ± 5-5%; P = 0-053). There was no significant change for seven patients with subtotal/total occlusions before hospital discharge (P = 011). LVEF tended to improve over time in both anterior and inferior infarcts, but the changes were not significant if analysed as two separate sub-groups.
Discussion
This small substudy of the European Cooperative Study, comparing the effects of rtPA and placebo on LV function, makes an important observation: the possibility of delayed recovery of LV function even after hospital discharge. This is not surprising in view of experimental evidence that reperfusion after <2 h of coronary occulsion in dogs resulted in salvage of jeopardized myocardium with gradual improvement of function of salvaged tissue requiring 3 weeks or more , similarly to the present results. The latter contrast ventriculographic study also looked at regional function and showed that late improvement of global function was due to an increased motion of the infarct region'" 1 . Similarly to the present observations, improvement was mainly seen in large infarcts, i.e. in patients with a depressed LVEF and not in those with a normal function shortly after the acute event. Those two papers" 8191 , however, either described survival in relation to LV function or regional function but did not stress the clinical relevance of late recovery of LV function.
For this study, time to peak CK was defined a priori as a marker of early reperfusion since all other clinical parameters of reperfusion are even less reliable 1201 . Unfortunately, no acute angiograms were performed as in the study by Schmidt el a/.' 181 where, again, late recovery of LV function was only found in patients with documented reperfusion. The 10 day angiogram in the present study also showed a difference in the extent of late recovery between patients with open vs those with subtotally or totally occluded infarct-related arteries. However, these angiographic findings reflect a 10-day vessel status and not early reperfusion since in the meantime spontaneous late (after hours or days) reperfusion and also silent reocclusion might have occurred in some patients, as observed in the European Cooperative Study and without (4/13; ns) signs of early reperfusion and have previously been shown not to change resting LVEF significantly 1211 . Although the sample size of this substudy may be too small to allow definite conclusions, the observations are in accordance with those of Schmidt et a/.
|18) as well as with experimental evidence of delayed functional recovery over weeks; they seem to imply that after acute myocardial infarction and thrombolysis LV function may not be definitely evaluated at hospital discharge. Studies analysing LV function within the first few days after acute myocardial infarction and thrombolysis should therefore be interpreted with caution. Thus, prolonged stunning might be one reason for the disparity between the effects of thrombolysis on infarct size and survival vs the lack of improvement in LV function reported in the literature.
